[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-342171-105":59,"doc-detail-342171-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","multi-omics-profiling-highlights-karyopherin-subunit-alpha-2-as-a-promising-biomarker-for-prognosis-and-immunotherapy-respond-in-pediatric-and-adult-adrenocortical-carcinoma","Multi-omics profiling highlights Karyopherin subunit alpha 2 as a promising biomarker for prognosis and immunotherapy respond in pediatric and adult adrenocortical carcinoma","","Adrenocortical carcinoma (ACC) affects pediatric and adult patients and is associated with poor prognosis and high mortality. Because conventional mitotane chemotherapy and emerging immunotherapy show inconsistent benefits and notable side effects, urgent work is needed to define new prognostic biomarkers and therapeutic targets. Using multi-omics datasets from TCGA and GEO, the study identifies KPNa2 as an independent risk factor linked to poor outcomes, supported by chromatin, expression, functional, and immune-infiltration evidence, and suggests KPNa2 may predict prognosis and immunotherapeutic response.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/multi-omics-profiling-highlights-karyopherin-subunit-alpha-2-as-a-promising-biomarker-for-prognosis-and-immunotherapy-respond-in-pediatric-and-adult-adrenocortical-carcinoma/342171/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/multi-omics-profiling-highlights-karyopherin-subunit-alpha-2-as-a-promising-biomarker-for-prognosis-and-immunotherapy-respond-in-pediatric-and-adult-adrenocortical-carcinoma/342171.png","ImageObject",300,407,{"name":92,"@type":93},"Evangeline","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-30","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main objective of the study on adrenocortical carcinoma?","Question",{"text":112,"@type":113},"To identify novel prognostic biomarkers and therapeutic targets for ACC, addressing the limited and inconsistent effectiveness of current chemotherapy and emerging immunotherapies.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was KPNa2 identified as a prognostic biomarker?",{"text":117,"@type":113},"Through multi-omics analyses using TCGA and GEO, including weighted gene co-expression network analysis, Cox regression, and ROC-based screening, followed by experimental validation and mechanistic exploration.",{"name":119,"@type":110,"acceptedAnswer":120},"What immune-related finding links KPNa2 with patient outcomes?",{"text":121,"@type":113},"Immune infiltration analysis showed reduced cD8+ T-cell infiltration in KPNa2-high cohorts, consistent with a more immunosuppressive tumor environment.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},342171,1790722966,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":56,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},13056703019662,"https://ap-avatar.wpscdn.com/avatar/be000253a8e92610077?_k=1778726343310543188","AnnAls of Medicine  \n2024, Vol. 56, no. 1, 2397092  \n[https://doi.org/10.1080/07853890.2024.2397092](https://doi.org/10.1080/07853890.2024.2397092)  \nReseaRch aRticle    \nMulti-omics profiling highlights karyopherin subunit alpha 2 as a promising biomarker for prognosis and immunotherapy respond in pediatric and adult adrenocortical carcinoma  \nYihao chena,b*, shumin Fangc*, chuanfan Zhongd,e, shanshan Moa, Yongcheng shib, Xiaohui lingd,e, Fengping liuf, Weide Zhongf,g, Junhong Denga, Zhong Dongb, Jiahong chenb and Jianming lua,g   \nadepartment of Andrology, Guangzhou first People’s Hospital, Guangzhou Medical University, Guangzhou, china; bdepartment of Urology, Huizhou central Hospital, Huizhou, china; cscience Research center, Huizhou central Hospital, Huizhou, china; ddepartment of Urology, Zhujiang Hospital, southern Medical University, Guangzhou, china; eReproductive Medicine center, Huizhou central Hospital, Huizhou, china; fstate Key laboratory of Quality Research in chinese Medicine, Macau University of science and Technology, Taipa, china; gdepartment of Urology, Guangdong Key laboratory of clinical Molecular Medicine and diagnostics, Guangzhou first People’s Hospital, Guangzhou Medical University, Guangzhou, china  \nABSTRACT  \nPurpose: adrenocortical carcinoma (acc) afflicts both pediatric and adult populations and is characterized by dismal prognosis and elevated mortality. Given the inconsistent therapeutic benefits and significant side effects associated with the conventional chemotherapy agent, mitotane, and the nascent stage of immunotherapy and targeted treatments, there is an urgent need to identify novel prognostic biomarkers and therapeutic targets in acc.  \nMethods: Utilizing multi-omic datasets from the cancer Genome atlas (tcGa) and the Gene expression Omnibus (GeO), we employed Weighted Gene co-expression Network analysis (WGcNa), cox regression, Receiver Operating characteristic (ROc) curves, and survival analyses to sift for potential prognostic biomarkers. We subsequently validated these findings through immunohistochemistry and cell assays, and delved into the biological role of KPNa2 in acc through functional enrichment analysis, mutational landscape, and immune cell infiltration. Results: a total of 77 progression-associated genes with aberrant chromosomal accessibility were discerned within the tcGa-acc dataset. By integrating ROc and cox regression from GeO datasets, KPNa2 emerged as an independent risk factor portending poor outcomes in acc. atac-seq analysis revealed attenuated chromatin accessibility of KPNa2 in cases with unfavorable prognosis. immunohistochemistry corroborated elevated KPNa2 expression, which was linked to enhanced proliferation and invasion. elevated KPNa2 levels were found to activate oncogenic pathways while simultaneously suppressing immunological responses. immune infiltration analysis further revealed a decrement in cD8+ t-cell infiltration in KPNa2-high cohorts.  \nConclusion: this study demonstrates the clinical and biological significance of KPNa2 in acc and suggests that KPNa2 could serve as a promising biomarker for predicting prognosis and immunotherapeutic responses in pediatric and adult acc patients.  \nARTICLE HISTORY  \nReceived 9 October 2023 Revised 15 December 2023  \naccepted 25 april 2024  \nKEYWORDS  \nadrenocortical carcinoma; atac-seq; KPNa2; prognosis; immunotherapy  \nIntroduction  \nadrenocortical carcinoma (acc) is a rare endocrine malignancy with an annual incidence rate of 0.5–2 cases per million adults and 0.2–0.3 cases per million children globally [1] . the overall 5-year survival rate for acc is a mere 35%, with stage 4 patients experiencing less than a 10% 5-year survival rate [2] . Various  \ntherapeutic approaches for acc encompass surgical resection, radiation therapy, chemotherapy, and targeted therapies [3,4] . For patients diagnosed at an early stage, surgical resection is typically the treatment of choice, especially when the tumor has not ","cbCaitAyAQl4hHwC","https://ap.wps.com/l/cbCaitAyAQl4hHwC","pdf",4702586,"English","# Introduction\n## Methods\n## Results\n## Conclusion","[{\"question\":\"What is the main objective of the study on adrenocortical carcinoma?\",\"answer\":\"To identify novel prognostic biomarkers and therapeutic targets for ACC, addressing the limited and inconsistent effectiveness of current chemotherapy and emerging immunotherapies.\"},{\"question\":\"How was KPNa2 identified as a prognostic biomarker?\",\"answer\":\"Through multi-omics analyses using TCGA and GEO, including weighted gene co-expression network analysis, Cox regression, and ROC-based screening, followed by experimental validation and mechanistic exploration.\"},{\"question\":\"What immune-related finding links KPNa2 with patient outcomes?\",\"answer\":\"Immune infiltration analysis showed reduced cD8+ T-cell infiltration in KPNa2-high cohorts, consistent with a more immunosuppressive tumor environment.\"}]","Multi-omics profiling highlights Karyopherin subunit alpha 2 as a promising biomarker for prognosis and immunotherapy respond in pediatric and adult adrenocortical carcinoma | PDF",1790045660,48,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/51662acb6174d0a44a2b816f0332b62c.webp",983,1280,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9410ed674ebde447dc36c65147378cf6.webp",982,1278,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/abeabb1033edcec160be780dfb8f9de3.webp",981,1277,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/016d3d89f64858736f992103a11b0eed.webp",980,1276]